High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Sven H. Loosen; Frank Tacke; Niklas Puthe; Marcel Binneboesel; Georg Wiltberger; Patrick H. Alizai; Jakob N. Kather; Pia Paffenholz; Thomas Ritz; Alexander Koch; Frank Bergmann; Christian Trautwein; Thomas Longerich; Christoph Roderburg; Ulf P. Neumann; Tom Luedde

doi:10.1093/carcin/bgz033

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Sven H. Loosen, Frank Tacke, Niklas Puthe, Marcel Binneboesel, Georg Wiltberger, Patrick H. Alizai, Jakob N. Kather, Pia Paffenholz, Thomas Ritz, Alexander Koch, Frank Bergmann, Christian Trautwein, Thomas Longerich, Christoph Roderburg, Ulf P. Neumann, Tom Luedde

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	947-955
Number of pages	9
Journal	Carcinogenesis
Volume	40
Issue number	8
DOIs	https://doi.org/10.1093/carcin/bgz033
Publication status	Published - Aug 2019

Keywords

CANCER
CELLS
UPAR
GEMCITABINE
SUPPRESSION
EXPRESSION
MORTALITY
DIAGNOSIS
GROWTH

Access to Document

10.1093/carcin/bgz033

Cite this

Loosen, S. H., Tacke, F., Puthe, N., Binneboesel, M., Wiltberger, G., Alizai, P. H., Kather, J. N., Paffenholz, P., Ritz, T., Koch, A., Bergmann, F., Trautwein, C., Longerich, T., Roderburg, C., Neumann, U. P., & Luedde, T. (2019). High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma. Carcinogenesis, 40(8), 947-955. https://doi.org/10.1093/carcin/bgz033

Loosen, Sven H. ; Tacke, Frank ; Puthe, Niklas ; Binneboesel, Marcel ; Wiltberger, Georg ; Alizai, Patrick H. ; Kather, Jakob N. ; Paffenholz, Pia ; Ritz, Thomas ; Koch, Alexander ; Bergmann, Frank ; Trautwein, Christian ; Longerich, Thomas ; Roderburg, Christoph ; Neumann, Ulf P. ; Luedde, Tom. / High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma. In: Carcinogenesis. 2019 ; Vol. 40, No. 8. pp. 947-955.

@article{c61f5440d80842f288c96ef739be3a29,

title = "High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma",

keywords = "CANCER, CELLS, UPAR, GEMCITABINE, SUPPRESSION, EXPRESSION, MORTALITY, DIAGNOSIS, GROWTH",

author = "Loosen, {Sven H.} and Frank Tacke and Niklas Puthe and Marcel Binneboesel and Georg Wiltberger and Alizai, {Patrick H.} and Kather, {Jakob N.} and Pia Paffenholz and Thomas Ritz and Alexander Koch and Frank Bergmann and Christian Trautwein and Thomas Longerich and Christoph Roderburg and Neumann, {Ulf P.} and Tom Luedde",

year = "2019",

month = aug,

doi = "10.1093/carcin/bgz033",

language = "English",

volume = "40",

pages = "947--955",

journal = "Carcinogenesis",

issn = "0143-3334",

publisher = "Oxford University Press",

number = "8",

}

Loosen, SH, Tacke, F, Puthe, N, Binneboesel, M, Wiltberger, G, Alizai, PH, Kather, JN, Paffenholz, P, Ritz, T, Koch, A, Bergmann, F, Trautwein, C, Longerich, T, Roderburg, C, Neumann, UP & Luedde, T 2019, 'High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma', Carcinogenesis, vol. 40, no. 8, pp. 947-955. https://doi.org/10.1093/carcin/bgz033

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma. / Loosen, Sven H.; Tacke, Frank; Puthe, Niklas; Binneboesel, Marcel; Wiltberger, Georg; Alizai, Patrick H.; Kather, Jakob N.; Paffenholz, Pia; Ritz, Thomas; Koch, Alexander; Bergmann, Frank; Trautwein, Christian; Longerich, Thomas; Roderburg, Christoph; Neumann, Ulf P.; Luedde, Tom.

In: Carcinogenesis, Vol. 40, No. 8, 08.2019, p. 947-955.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

AU - Loosen, Sven H.

AU - Tacke, Frank

AU - Puthe, Niklas

AU - Binneboesel, Marcel

AU - Wiltberger, Georg

AU - Alizai, Patrick H.

AU - Kather, Jakob N.

AU - Paffenholz, Pia

AU - Ritz, Thomas

AU - Koch, Alexander

AU - Bergmann, Frank

AU - Trautwein, Christian

AU - Longerich, Thomas

AU - Roderburg, Christoph

AU - Neumann, Ulf P.

AU - Luedde, Tom

PY - 2019/8

Y1 - 2019/8

KW - CANCER

KW - CELLS

KW - UPAR

KW - GEMCITABINE

KW - SUPPRESSION

KW - EXPRESSION

KW - MORTALITY

KW - DIAGNOSIS

KW - GROWTH

U2 - 10.1093/carcin/bgz033

DO - 10.1093/carcin/bgz033

M3 - Article

C2 - 30805627

VL - 40

SP - 947

EP - 955

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 8

ER -